FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry and represents the use of lanost-8,24-dien-3-ols for preparing pharmaceutical compositions inhibiting higher activation of serine/threonine protein kinases, or modulated transcription factors.
EFFECT: invention provides the use of lanost-8,24-dien-3-ols as anti-inflammatory, anticancer, analgesic agents acting by inhibition of enzymes activity of which is related with proliferation of specific types of cancer.
15 cl, 5 ex, 10 dwg
